This section is intended for members of the public. If you have been prescribed ADCETRIS click here. If you are a UK healthcare professional click here.

Lymphoma Information & Support

Hodgkin lymphoma (HL) and systemic Anaplastic Large Cell Lymphoma (sALCL)

Information for members of the public

The information within this section of the website is intended for members of the public. Here you will find general information about HL and sALCL.

If you have been prescribed ADCETRIS (brentuximab vedotin) please visit the patient section of this website.

Help and support from charities

These charities can give you information, practical advice and support about living with Hodgkin lymphoma (HL), or systemic Anaplastic Large Cell Lymphoma (sALCL):

Lymphoma Association

Lymphoma Association

0808 808 5555

Bloodwise

Bloodwise

0808 2080 888

Leukaemia Care

Leukaemia Care

0808 801 0444

Reporting of side effects

ADCETRIS (brentuximab vedotin) is subject to additional monitoring. This will allow quick identification of new safety information.
You can help by reporting any side effects you may get. If you get any side effects whilst taking ADCETRIS, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed on this website or in the patient information leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects you can help provide more information on the safety of this medicine.